Cargando…
Corrigendum: IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171451/ https://www.ncbi.nlm.nih.gov/pubmed/36724044 http://dx.doi.org/10.17305/bb.2022.8739 |
Ejemplares similares
-
IC(50): an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation
por: Xu, Yipeng, et al.
Publicado: (2022) -
Corrigendum to “A Chemically Defined Serum-Free Culture System for Spontaneous Human Mesenchymal Stem Cell Spheroid Formation”
por: Zhao, Yajun, et al.
Publicado: (2020) -
HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]
Publicado: (2019) -
Corrigendum to “The Effect of Cochlear Size on Cochlear Implantation Outcomes”
por: Kuthubutheen, Jafri, et al.
Publicado: (2020) -
Development of cabozantinib for the treatment of prostate cancer [Corrigendum]
Publicado: (2014)